Brilique 90 mg film-coated tablets

Company
AstraZeneca Pharmaceuticals (Ireland) DAC
Active Ingredient
Dosage Form
Film-coated tablet
Legal Category
B - prescription, may be renewed

*further information is available on request to the holder of the authorisation or in the SPC

Licence number Strength ATC Code Dosage Form
EU/1/10/655/001 90 milligram(s) B01AC24 Film-coated tablet
EU/1/10/655/002 90 milligram(s) B01AC24 Film-coated tablet
EU/1/10/655/003 90 milligram(s) B01AC24 Film-coated tablet
EU/1/10/655/004 90 milligram(s) B01AC24 Film-coated tablet
EU/1/10/655/005 90 milligram(s) B01AC24 Film-coated tablet
EU/1/10/655/006 90 milligram(s) B01AC24 Film-coated tablet
Licence number
EU/1/10/655/001
Strength
90 milligram(s)
ATC Code
B01AC24
Dosage Form
Film-coated tablet
Licence number
EU/1/10/655/002
Strength
90 milligram(s)
ATC Code
B01AC24
Dosage Form
Film-coated tablet
Licence number
EU/1/10/655/003
Strength
90 milligram(s)
ATC Code
B01AC24
Dosage Form
Film-coated tablet
Licence number
EU/1/10/655/004
Strength
90 milligram(s)
ATC Code
B01AC24
Dosage Form
Film-coated tablet
Licence number
EU/1/10/655/005
Strength
90 milligram(s)
ATC Code
B01AC24
Dosage Form
Film-coated tablet
Licence number
EU/1/10/655/006
Strength
90 milligram(s)
ATC Code
B01AC24
Dosage Form
Film-coated tablet

AstraZeneca Pharmaceuticals (Ireland) DAC

College Business and Technology Park, Blanchardstown Road North, Dublin 15, D15 R925, D15 R925 Dublin

Website
https://contactazmedical.astrazeneca.com
Telephone
+35316097100
Email
mipqc.ireland@astrazeneca.com